Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.ZYBT
3 quarters
Position history for JPMorgan Chase & Co.'s holdings in Zhengye Biotechnology Holding Limited
Yes. JPMorgan Chase holds 134 shares of ZYBT (Zhengye Biotechnology Holding), worth $93, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$93
Current Shares
134
Total Value Change
-$433
Total Shares Change
-323
Quarter-by-Quarter History
Other major holders of ZYBT: Jane Street Group, LLC, UBS Group AG, Invesco Ltd., Geode Capital Management, LLC